Vol 3, No 2 (2000)
Brief communication
Published online: 2003-05-27
Recombinant human TSH for the treatment of differentiated thyroid cancer metastatic to the spine
Nucl. Med. Rev 2000;3(2):157-160.
Abstract
The diagnostic use of recombinant human TSH (rhTSH) in follow-
up of differentiated thyroid cancer (DTC) is already approved,
however its application in 131I therapy is still to be evaluated.
We report results obtained in four patients with DTC
metastatic to central skeleton, in whom 5 courses of rtTSH aided
131I therapy were administered.
Keywords: recombinant human TSHdifferentiated thyroid cancerradioiodine therapy
